Semler Scientific’s High-Stakes Bitcoin Strategy Divides Investors

Semler Scientific finds itself navigating a precarious dual-path strategy that has placed shareholders in a challenging position. The company’s recent quarterly performance highlights a fundamental tension between its established healthcare operations and its substantial cryptocurrency investments, creating uncertainty about its future direction.

The third quarter 2025 financial report painted a contradictory picture of Semler Scientific’s business trajectory. Operational revenue remained modest at approximately $7.49 million, reflecting the mature market position of its QuantaFlo diagnostic product. However, net income surged dramatically to $16.9 million, driven exclusively by a $28.49 million appreciation in the company’s Read more...